Peter Johnson
Directeur des opérations chez Next Frontier Biosciences, Inc. (Colorado)
Provenance du réseau au premier degré de Peter Johnson
Entité | Type d'entité | Industrie | |
---|---|---|---|
Next Frontier Biosciences, Inc. (Colorado)
Next Frontier Biosciences, Inc. (Colorado) Pharmaceuticals: OtherHealth Technology Next Frontier Biosciences LLC develops and manufactures purified cannabinoid products for the treatment of chronic pain and other serious medical conditions. It offers nasal mist, topical salve, and sublingual spray. The company was founded by Marc Graboyes and Paul Johnson in 2014 and is headquartered in Westminster, CO.
6
| Private Company | Pharmaceuticals: Other | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peter Johnson via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
PHASERX, INC. | Pharmaceuticals: Major | Founder | |
The State University of New York | College/University | Doctorate Degree | |
EpigenX Pharmaceuticals, Inc. | Chief Tech/Sci/R&D Officer | ||
SRI International
SRI International Miscellaneous Commercial ServicesCommercial Services SRI International provides contract research and development services. It is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. The company was founded in 1946 and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Wayne State University School of Medicine | College/University | Corporate Officer/Principal | |
Allos Therapeutics, Inc.
Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | General Counsel | |
The University of Colorado | College/University | Graduate Degree | |
Perkins Coie LLP
Perkins Coie LLP Miscellaneous Commercial ServicesCommercial Services Perkins Coie LLP provides corporate, commercial litigation, and intellectual property legal services. Its practice areas include business law, environment and natural resources, estate planning and trust services, finance, intellectual property, labor and employment, litigation, product liability, real estate and land use, regulatory and government affairs, and taxation. The company was founded in 1912 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Next Frontier Brands
Next Frontier Brands Food DistributorsDistribution Services Next Frontier Brands engages in the provision of consumer goods. It offers beverage and hemp-based wellness brands. The company is headquartered in Boulder, CO. | Food Distributors | President |
Statistiques
Internationale
Etats-Unis | 13 |
Allemagne | 2 |
Sectorielle
Commercial Services | 5 |
Health Technology | 4 |
Consumer Services | 4 |
Distribution Services | 2 |
Opérationnelle
Corporate Officer/Principal | 8 |
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 4 |
Founder | 3 |
Undergraduate Degree | 2 |
Relations les plus connectées
Insiders | |
---|---|
Paul Johnson | 9 |
Marc H. Graboyes | 6 |
Charles Sander | 1 |
James Kreitman | 1 |
Stephen Cape | 1 |
Shawn Zinnen | 1 |
- Bourse
- Insiders
- Peter Johnson
- Connexions Sociétés